Baxdrostat is one of several drugs AstraZeneca is developing in cardiovascular, renal, and metabolic disease areas. The company gained rights to the drug in 2023 after acquiring CinCor Pharma in a ...

Read More »

AstraZeneca exit: here’s what it really means for the UK

AstraZeneca is reportedly considering moving its listing to the US. Here's why AZN's expected departure is alarming for the UK.

Read More »

AstraZeneca completes EsoBiotec acquisition for up to $1bn

AstraZeneca PLC (LSE/STO/Nasdaq:LON: AZN), the global biopharmaceutical company, has announced the completion of its acquisition of EsoBiotec, a biotech company specializing in cell therapies, for a ...

Read More »

AstraZeneca (LON:AZN) Is Posting Promising Earnings But The Good News ...

AstraZeneca PLC (LON:AZN) announced a healthy earnings result recently, and the market rewarded it with a strong uplift in the stock price. This reaction by the market reaction is understandable when ...

Read More »

AstraZeneca's new 2030 targets are bold attempt to reach for the stars ...

Proactive Investors - After AstraZeneca PLC (LON: AZN) unveiled new sales and profit targets for the end of the decade, analysts were mildly impressed by the ambition to "shoot for the stars".

Read More »